(A Top Pick Aug 26/15. Down 2.3%.) After the latest quarter, the obituary has been retracted for now. This is a company and a stock that everyone has an opinion on. It is a highly bifurcated view in that they really love it, or don’t like it at all. You have to remember that this is a company that has been adopted by a great many people as their way of adopting the mobile experience. Thinks that iPhone 7 coming this fall, will be very, very successful. Valuation is extremely attractive, 30% of their market capitalization is in cash, and it is trading at a single digit multiple.

(A Top Pick Aug 26/15. Up 4.48%.) This has about a half $1 trillion backlog, 5700 airplanes. It is a cash flow story. Their capital expenditure program has really peaked, which means greater and greater free cash flow.

(A Top Pick Aug 26/15. Up 10.69%.) This is really a story about the housing market. There needs to be a lot more household formations to satisfy the population growth. 5 years ago, net margins were about 2%, last year they were 5%, and by the end of the decade he thinks they will be over 7%.

Sold his holdings in Q1 of 2015 because of concerns of the Chinese claiming that the company was monopolistic as well as some issues of patent infringement. The stock has been flat to down since then, and those concerns really haven’t gone away. Apple (AAPL-Q) has been a fairly large customer, but there are rumours that Apple will be using Intel (INTC-Q) chips, for the iPhone 7, at least in part.

He is still positive on this, and it has done relatively well of late. Just reported, and earnings were a little bit soft, but it has had a very, very positive move since the early part of the year. The US’s infrastructure is wanting, whether it is roads and bridges, airports, etc. that they just haven’t poured the money in to refurbish and repair. This is one of the largest commercial construction companies, and should do well.

Just recently reported, and had a very, very strong quarter. This is a pharmacy that fills a lot of prescriptions. It is also a pharmacy benefits manager, so they are a consolidator and a representative for large groups. There are a lot of things going for a company like this, such as aging demographics, and greater US insurance for people.

He is positive on this. It is a story about volume and technology. They are increasing margins very effectively through using different tools.